Head-to-head · Value Score
Enhance MD vs Eden
Two GLP-1 deals, scored on the same six factors. Enhance MD lands a Value Score of 85, Eden a 81. Here's who gives you the honest lower price — and where each one bites back.
Enhance MD
#16 · Grade A- · Great Deal
Est. first month
$249 every 4 weeks (13 charges a year)
Save ~87% vs brand-nameEden
#60 · Grade B · Good Value
Est. first month
$239/mo
Save ~82% vs brand-nameFDA warning letter. The FDA issued Eden Health International Inc. dba Eden a warning letter in June 2026. Check it on the FDA database.
Get this deal Full Eden review →The verdict
Enhance MD takes it on Value Score, 85 to 81 — an est. $249 every 4 weeks (13 charges a year) first month, though we flag its pricing to watch. Eden isn't out of it: Shoppers who'll trade a lower price for maximum disclosure and rock-solid nationwide access.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Enhance MD | Eden |
|---|---|---|
| Value Score | 85 (A-) | 81 (B) |
| Est. first month | $249 every 4 weeks (13 charges a year) | $239/mo |
| Save vs brand-name | ~87% | ~82% |
| Semaglutide | $249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay | $239/mo |
| Tirzepatide | $329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay | $349/mo |
| Both molecules | Yes | Yes |
| Pricing | Watch | Flat — no step-up |
| Coverage | Not publicly listed | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Enhance MD
A transparent, dose-flat compounded menu (microdose to sema+tirz combo) with 6-month lab testing and NAD+ on the side — priced higher at entry, with a first-month sema teaser to read past.
Why it's a deal
- Transparent, dose-flat tiered pricing published up front (microdose, sema, tirz, combo)
- Includes 6-month lab testing and provider-led care rather than a bare prescription
- NAD+ and adjacent longevity support available on the same platform
The fine print
- Compounded only — not FDA-approved, and no brand-name or oral/sublingual route
- Semaglutide's $112 first month steps up to $212 — a teaser to plan around
- Higher entry price than the rock-bottom flat-fee programs
- States served are not publicly listed — confirm coverage before you sign up
Eden
The priciest of the top programs we track, but the most transparent — you pay up, never get baited.
Why it's a deal
- Highest transparency — clear supply-chain and clinician disclosure
- Available in all 50 states
- Both molecules offered, no teaser tier
The fine print
- Most expensive on semaglutide among the top programs ($239/mo)
- Compounded only — no brand-name access
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Enhance MD is ranked on the Enhance MD alternatives ranking, and the same list for the other side is on alternatives to Eden.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.